Skip to main content
. 2024 Jan 4;30(1):e13544. doi: 10.1111/srt.13544

FIGURE 1.

FIGURE 1

(A) Morphological analysis of the cells using an inverted microscope (×100). (B) MTT assay results in 24 h after CAP application. CAP selectively diminished the viability of B16 melanoma cancer cells in a dose‐response manner, while it not affected on the viability of normal L929 cells. The tests were performed three times.